CWM »

Lineage Cell Therapeutics In shares owned by CWM

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by CWM from 13F filings

Historical chart of CWM investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by CWM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by CWM

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.0k 1.5k 1.32
2021-12-31 $0 35 0.00
2020-06-30 $13k 15k 0.86
2020-03-31 $13k 15k 0.86
2019-12-31 $14k 15k 0.92
2019-09-30 $15k 15k 0.99

More positions owned by CWM

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Microsoft Corporation (MSFT)
Apple (AAPL)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Eafe Value Etf (EFV)
Pimco Etf Tr Active Bd Etf (BOND)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Ser Tr Portfolio S&p400 (SPMD)

View all positions for CWM

Top funds holding Lineage Cell Therapeutics In

Vanguard Group
Defender Capital
Raffles Associates
Prescott General Partners
MAI Wealth Advisors
Jpmorgan Chase & Co
Citadel Advisors
Laurion Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Long Focus Capital Management
Barclays
Royal Bank of Canada
Squarepoint Ops
Jane Street

View all funds holding Lineage Cell Therapeutics In